Clinical trial
Open Label Treatment of Patients With Chronic Hand Dermatitis Who Have Participated in a Previous Clinical Trial Involving Oral Alitretinoin
NCT00519675 is registered in ClinicalTrials.gov with Basilea Pharmaceutica as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open Label Treatment of Patients With Chronic Hand Dermatitis Who Have Participated in a Previous Clinical Trial Involving Oral Alitretinoin
- Lead sponsor
- Basilea Pharmaceutica
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 2007
- Completion date
- Not reported
- Enrollment
- 150 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.